An interdisciplinary project with the aim to develop new technologies for the detection of subvisible to visible particles in complex drug product formulations within the pharmaceutical industry.
Would you like to work with pharmaceutically relevant peptides/proteins in a collaboration between the Technical University of Denmark - DTU and Novo Nordisk? And would you like to join the journey to help Novo Nordisk solve challenges in the characterization of next generation drug products?
Then apply now for this exciting PhD position!
The position
The pharmaceutical industry is entering a transformative phase with the rise of complex biopharmaceuticals, such as microcarriers, suspensions, and stem cell therapies. However, existing analytical technologies are insufficient to meet the characterization needs of these novel drug products. To address this challenge, Novo Nordisk A/S is offering a three-year industrial PhD position in collaboration with DTU Health Tech (Prof. Anders Kristensen, ), aimed at developing new characterization technologies for next generation complex biopharmaceuticals.
The cutting-edge PhD project will focus on developing innovative microfluidic cells to separate pharmaceutically relevant foreign extrinsic particles (impurities) from complex co-formulated drug product entities. You will explore and integrate advanced detection systems, such as Raman spectroscopic sensors and high-speed image sensors, and develop machine learning algorithms for particle identification. The goal is to evaluate the scalability and industrial application of this combined system that could revolutionize the traditional analysis and quality control of complex biopharmaceuticals.
Key Responsibilities
As a candidate you will:
Qualifications
It will help your application if you have experience with one or more of the subjects below:
What We Offer
Application procedure
The application, in English, must be submitted electronically by clicking APPLY NOW below.
Your application must include:
Husk at skrive i din ansøgning, at du så jobbet hos Ofir